2-adamantanamine

ID: ALA1170792

Cas Number: 13074-39-0

PubChem CID: 25332

Product Number: A586946, Order Now?

Max Phase: Preclinical

Molecular Formula: C10H17N

Molecular Weight: 151.25

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Synonyms: 2-Adamantanamine | 2-aminoadamantane|adamantan-2-amine|13074-39-0|2-Adamantanamine|2-Adamantylamine|Tricyclo[3.3.1.13,7]decan-2-amine|JP 60|adamantan-2-ylamine|CHEMBL1170792|MFCD00078225|Tricyclo(3.3.1.1(3,7))decan-2-amine|Tricyclo(3.3.1.13,7)decan-2-amine|2-amino-adamantane|NSC 127842|Oprea1_605085|SCHEMBL75970|AC17|SCHEMBL2400612|SCHEMBL4657616|SCHEMBL4688717|SCHEMBL7436572|SCHEMBL12876277|SCHEMBL13243472|SCHEMBL15088151|SCHEMBL17203865|DTXSID90156707|HMS1787I03|BDBM50482329|NSC127842|AKOS0001Show More

Synonyms from Alternative Forms(1): Adamantan-2-Ylamine HCl

Canonical SMILES:  NC1C2CC3CC(C2)CC1C3

Standard InChI:  InChI=1S/C10H17N/c11-10-8-2-6-1-7(4-8)5-9(10)3-6/h6-10H,1-5,11H2

Standard InChI Key:  QZWNXXINFABALM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 11 13  0  0  0  0  0  0  0  0999 V2000
   -4.1041   -9.6838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4582   -8.9951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2938   -9.4571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7415   -9.2555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5355   -9.7579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9882   -9.0686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2965   -8.5983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7358   -7.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4627   -8.1895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9823   -8.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2906   -7.7828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  6  1  0
  7  8  1  0
  3  7  1  0
  2  9  1  0
  6 10  1  0
 10  8  1  0
  8  9  1  0
 10 11  1  0
M  END

Alternative Forms

  1. Alternative Forms:

  2. Parent:

Associated Targets(non-human)

M Matrix protein 2 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza B virus (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M Influenza virus A matrix protein M2 (517 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 151.25Molecular Weight (Monoisotopic): 151.1361AlogP: 1.77#Rotatable Bonds:
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.54CX LogP: 1.55CX LogD: -1.23
Aromatic Rings: Heavy Atoms: 11QED Weighted: 0.56Np Likeness Score: 0.23

References

1. Eleftheratos S, Spearpoint P, Ortore G, Kolocouris A, Martinelli A, Martin S, Hay A..  (2010)  Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.,  20  (14): [PMID:20570509] [10.1016/j.bmcl.2010.05.049]
2. Kolocouris A, Tzitzoglaki C, Johnson FB, Zell R, Wright AK, Cross TA, Tietjen I, Fedida D, Busath DD..  (2014)  Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.,  57  (11): [PMID:24793875] [10.1021/jm500598u]
3. Tzitzoglaki C, Wright A, Freudenberger K, Hoffmann A, Tietjen I, Stylianakis I, Kolarov F, Fedida D, Schmidtke M, Gauglitz G, Cross TA, Kolocouris A..  (2017)  Binding and Proton Blockage by Amantadine Variants of the Influenza M2WT and M2S31N Explained.,  60  (5): [PMID:28107633] [10.1021/acs.jmedchem.6b01115]
4. Wu S, Wang Y, Liu N, Dong G, Sheng C..  (2017)  Tackling Fungal Resistance by Biofilm Inhibitors.,  60  (6): [PMID:28051303] [10.1021/acs.jmedchem.6b01203]

Source